• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Claims superior lens: Mexico's Augen Opticos announces U.S. launch

Article

Ensenada, Mexico-Augen Opticos is introducing to the United States a line of aspheric, high-index lenses it claims is superior to other aspheric products for its optics and ease of processing.

Related Videos
Related Content
Gene editing untangles one strand of the AMD web

Gene editing untangles one strand of the AMD web

Article
Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast
WVU Medicine to expand, relocate WVU Eye Institute

WVU Medicine to expand, relocate WVU Eye Institute

Article
EyePod: Modifier Gene Therapy: What is it?

EyePod: Modifier Gene Therapy: What is it?

Podcast
Ocugen completes dosing of subjects with geographic atrophy in Cohort 2 of Phase 1/2 ArMaDa clinical trial of OCU410

Ocugen completes dosing of subjects with geographic atrophy in Cohort 2 of Phase 1/2 ArMaDa clinical trial of OCU410

Article
ARVO flying high in Seattle

ARVO flying high in Seattle

Article
© 2024 MJH Life Sciences

All rights reserved.